Mitochondrial Complex III

Migration, Crosslink

📖

Mitochondrial Complex III

active

wiki page Created: 2026-04-02T07:19:53 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-mitochondrial-complex-ii

📖 Wiki Page

mechanism1462 wordssynced 2026-04-02

Mitochondrial Complex III

Introduction

Mitochondrial Complex Iii is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Mitochondrial Complex III (Cytochrome bc1 Complex or Ubiquinol-Cytochrome c Reductase) is a central component of the Electron Transport Chain (ETC). It catalyzes the transfer of electrons from ubiquinol (CoQH2) to cytochrome c while simultaneously pumping protons across the inner mitochondrial membrane, contributing to the establishment of the proton gradient that drives ATP synthesis. [@zhang1998]

Complex III (Cytochrome bc1) Pathway

flowchart TD A["Ubiquinol CoQH2 -> BComplex III Cytochrome bc1"] subgraph Q_Cycle B --> C["First Electron to Cytochrome c"] C --> D["Second Electron to Ubiquinone"] D --> E["Ubiquinol Regenerated"] end E --> A B --> F["Cytochrome c Reduced"] F --> G["Complex IV"] H["Protons H+ --> IIntermembrane Space"] B -->|"Pump H+"| I style A fill:#1a0a1f,stroke:#333,color:#e0e0e0 style F fill:#3a3000,stroke:#333,color:#e0e0e0 style I fill:#9f9,stroke:#333,color:#0d0d1a

Overview

...

Mitochondrial Complex III

Introduction

Mitochondrial Complex Iii is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Mitochondrial Complex III (Cytochrome bc1 Complex or Ubiquinol-Cytochrome c Reductase) is a central component of the Electron Transport Chain (ETC). It catalyzes the transfer of electrons from ubiquinol (CoQH2) to cytochrome c while simultaneously pumping protons across the inner mitochondrial membrane, contributing to the establishment of the proton gradient that drives ATP synthesis. [@zhang1998]

Complex III (Cytochrome bc1) Pathway

Mermaid diagram (expand to render)

Overview

Complex III occupies a critical position in the ETC, receiving electrons from Complex I and Complex II via ubiquinol and transferring them to cytochrome c, which then carries them to Complex IV. This electron transfer is coupled with proton pumping, making Complex III essential for cellular energy production. Dysfunction of Complex III has been implicated in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and MELAS syndrome. [@hunte2000]

Structure

Complex III is a symmetric dimer, with each monomer containing 11 subunits that work together to catalyze electron transfer and proton pumping: [@rich2010]

Core Catalytic Subunits

Cytochrome b: The largest subunit, containing two heme b groups (bL and bH) that serve as electron acceptors. The low-potential heme bL and high-potential heme bH are positioned on opposite sides of the inner membrane.
Rieske Iron-Sulfur Protein (ISP, UCRF1): Contains a 2Fe-2S cluster that undergoes redox changes during electron transfer. The ISP has a mobile head domain that shuttles between cytochrome c1 and cytochrome b.
Cytochrome c1: A heme-containing protein that receives electrons from the ISP and passes them to cytochrome c.

Additional Subunits

Core protein 1 (UQCRFS1): Part of the core matrix arm
Core protein 2 (UQCRB): Stabilizes the complex
Core protein 3 (UQCRH): Assembly factor
Cytochrome b-C1 fusion protein: Additional regulatory subunit
Superoxide dismutase 1 (SOD1): Associated with the complex
Other small subunits: Provide structural stability

Function

Q Cycle Mechanism

The Q cycle is the fundamental mechanism by which Complex III transfers electrons and pumps protons: [@sazanov2013]

First ubiquinol oxidation: The first ubiquinol (CoQH2) binds to the Qo site. It donates one electron to the 2Fe-2S cluster of the ISP and one electron to heme bL. The ISP then passes its electron to cytochrome c1 and subsequently to cytochrome c. The two protons released from ubiquinol are pumped across the inner membrane.

Second ubiquinol oxidation: A second ubiquinol binds to the Qo site. One electron goes through the same ISP-cytochrome c1 pathway to cytochrome c. The other electron goes to heme bL, then to heme bH, and finally reduces ubiquinone (CoQ) to ubiquinol at the Qi site.

This elegant mechanism allows Complex III to pump four protons per pair of electrons transferred while also regenerating ubiquinol for continued electron flow. [@castellani2002]

Proton Pumping

Stoichiometry: 4 protons pumped per electron pair (2 protons per ubiquinol oxidized)
Proton motive force: The proton gradient created drives ATP synthase (Complex V)
Coupling efficiency: Critical for maintaining cellular energy homeostasis

Electron Transfer Pathway

The sequential electron transfer within Complex III follows this path: [@parker1990]
Ubiquinol → 2Fe-2S → Cytochrome c1 → Cytochrome c
↓
Heme bL → Heme bH → Ubiquinone

Regulation

Post-Transcriptional Regulation

Phosphorylation: Multiple phosphorylation sites modulate Complex III activity
Acetylation: Metabolic status affects acetylation levels of core subunits

Quality Control

Assembly factors: Specialized proteins assist in complex formation
Turnover: Damaged Complex III components are degraded and replaced

Neurodegeneration Relevance

Alzheimer's Disease (AD)

Complex III dysfunction in AD contributes to disease pathogenesis through multiple mechanisms: [@lin2006]

Electron leak and ROS generation: Impaired electron flow leads to increased superoxide production at the Qo site
Amyloid-beta interaction: Aβ binds to Complex III, inhibiting its activity and enhancing ROS production
Mitochondrial dynamics disruption: Complex III dysfunction affects mitochondrial fission/fusion balance
Bioenergetic failure: Reduced ATP production contributes to synaptic dysfunction and neuronal death
Tau pathology relationship: Hyperphosphorylated tau affects mitochondrial transport and function

Evidence: Post-mortem studies show reduced Complex III activity in AD brains, particularly in the hippocampus and temporal cortex. Cytochrome b mutations have been associated with early-onset AD in some families. [@schapira1998]

Parkinson's Disease (PD)

Complex III plays a complex role in PD pathophysiology: [@wallace1999]

Complex I deficiency compensation: Reduced Complex I activity may increase reliance on Complex III
α-Synuclein interaction: α-Synuclein oligomers can bind to mitochondrial Complex III, impairing its function
LRRK2 mutations: G2019S LRRK2 affects mitochondrial function including Complex III activity
PINK1/Parkin pathway: Impaired mitophagy leads to accumulation of dysfunctional Complex III

Evidence: While Complex I deficiency is the most well-established mitochondrial defect in PD, Complex III dysfunction also contributes to dopaminergic neuron vulnerability. [@finsterer2007]

MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes)

mtDNA mutations: A3243G and other mtDNA mutations in the cytochrome b gene impair Complex III assembly and function
Heteroplasmy: The percentage of mutated mtDNA determines disease severity
Energy failure: Reduced Complex III activity causes severe ATP depletion
Lactic acidosis: Impaired oxidative phosphorylation leads to glycolytic compensation and lactic acidosis
Stroke-like episodes: Mitochondrial dysfunction in endothelial cells contributes to vascular dysfunction

Amyotrophic Lateral Sclerosis (ALS)

SOD1 mutations: Mutant SOD1 can impair Complex III function
Energy metabolism: Motor neurons are particularly vulnerable to Complex III dysfunction due to their high energy demands
Oxidative stress: Complex III dysfunction increases ROS, contributing to motor neuron degeneration

Huntington's Disease (HD)

Mutant HTT effects: Huntingtin protein affects mitochondrial Complex III function
Energy deficits: Reduced Complex III activity contributes to striatal neuron vulnerability
Oxidative damage: Increased ROS from Complex III dysfunction

Therapeutic Implications

Potential Therapeutic Strategies

CoQ10 supplementation: Can improve electron transfer and bypass some Complex III defects

Targeting ROS: Antioxidants targeting mitochondrial ROS (e.g., MitoQ) may protect neurons

Gene therapy: Potential for delivering wild-type mtDNA or editing mutant mtDNA

Small molecule modulators: Compounds that enhance Complex III assembly or function

Challenges

Complex III is encoded by both nuclear and mitochondrial DNA
mtDNA mutations are difficult to target with traditional therapeutics
Heteroplasmy levels complicate treatment approaches

Background

The study of Mitochondrial Complex Iii has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@thambisetty2007]

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Confidence Assessment

🔴 Low Confidence

| Dimension | Score |
|-----------|-------|
| Supporting Studies | 12 references |
| Replication | 0% |
| Effect Sizes | 25% |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 50% |

Overall Confidence: 34%

Recent Research Updates (2024-2026)

[Stoolman JS et al., Nat Metab (2024 Aug)](https://pubmed.ncbi.nlm.nih.gov/39048801/)
[Chang JC et al., Cells (2025 Jul 25)](https://pubmed.ncbi.nlm.nih.gov/40801581/)
[Niño SA et al., Biochim Biophys Acta Mol Basis Dis (2026 Mar 3)](https://pubmed.ncbi.nlm.nih.gov/41785939/)
[Huayta J et al., bioRxiv (2025 Oct 23)](https://pubmed.ncbi.nlm.nih.gov/41278705/)
[Zhang J et al., Mol Neurobiol (2025 Oct)](https://pubmed.ncbi.nlm.nih.gov/40588669/)

References

Trumpower BL, The protonmotive Q cycle (1990)

Zhang Z, Huang L, Shulmeister VM, Kim YW, Berry EA, Electron transfer by domain movement in cytochrome bc1 (1998)

Hunte C, Koepke J, Lange C, Roßmanith T, Michel H, Structure at 2.3 Å resolution of the cytochrome bc1 complex from the yeast Saccharomyces cerevisiae (2000)

Unknown, Rich PR, Maréchal A. The mitochondrial respiratory chain (2010)

Sazanov LA, A giant molecular proton pump in the respiratory chain (2013)

Castellani R, Hirai K, Aliev G, et al, Role of mitochondrial dysfunction in Alzheimer's disease (2002)

Parker WD Jr, Filley CM, Parks JK, Complex I deficiency in Alzheimer's disease frontal cortex (1990)

Lin MT, Beal MF, Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases (2006)

Schapira AH, Mitochondrial involvement in Parkinson's disease (1998)

Wallace DC, Mitochondrial diseases in man and mouse (1999)

Finsterer J, Hematological manifestations of primary mitochondrial disorders (2007)

Thambisetty M, Newman NJ, Measurement of mitochondrial cytochrome bc1 complex activity in skeletal muscle (2007)

📖 View canonical wiki page →

Related Entities

mechanisms-mitochondrial-complex-iii

▸Metadataorigin_type: v1_polymorphic_backfill

slug	mechanisms-mitochondrial-complex-iii
kg_node_id	None
entity_type	mechanism
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-2d7b47111bea
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'mechanisms-mitochondrial-complex-iii'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

75

Outgoing

100

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Mitochondrial Complex III

Mitochondrial Complex III

Introduction

Complex III (Cytochrome bc1) Pathway

Overview

Mitochondrial Complex III

Introduction

Complex III (Cytochrome bc1) Pathway

Overview

Structure

Core Catalytic Subunits

Additional Subunits

Function

Q Cycle Mechanism

Proton Pumping

Electron Transfer Pathway

Regulation

Post-Transcriptional Regulation

Quality Control

Neurodegeneration Relevance

Alzheimer's Disease (AD)

Parkinson's Disease (PD)

MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes)

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease (HD)

Therapeutic Implications

Potential Therapeutic Strategies

Challenges

See Also

Background

External Links

Confidence Assessment

Recent Research Updates (2024-2026)

References

💬 Discussion